MFDS — authorised 20 November 2008
- Marketing authorisation holder: NOVARTIS PHARMS CORP
- Status: likely_approved
🇰🇷 Promacta in South Korea
MFDS authorised Promacta on 20 November 2008
Marketing authorisation
Promacta in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Promacta approved in South Korea?
Yes. MFDS authorised it on 20 November 2008.
Who is the marketing authorisation holder for Promacta in South Korea?
NOVARTIS PHARMS CORP holds the South Korean marketing authorisation.